JP2012143242A5 - - Google Patents

Download PDF

Info

Publication number
JP2012143242A5
JP2012143242A5 JP2012071880A JP2012071880A JP2012143242A5 JP 2012143242 A5 JP2012143242 A5 JP 2012143242A5 JP 2012071880 A JP2012071880 A JP 2012071880A JP 2012071880 A JP2012071880 A JP 2012071880A JP 2012143242 A5 JP2012143242 A5 JP 2012143242A5
Authority
JP
Japan
Prior art keywords
seq
shows
amino acid
acid sequence
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012071880A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012143242A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012143242A publication Critical patent/JP2012143242A/ja
Publication of JP2012143242A5 publication Critical patent/JP2012143242A5/ja
Withdrawn legal-status Critical Current

Links

Images

JP2012071880A 2000-01-10 2012-03-27 乳癌において差次的に発現される遺伝子 Withdrawn JP2012143242A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10
US60/175,462 2000-01-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2001551099A Division JP5250168B2 (ja) 2000-01-10 2001-01-09 乳癌において差次的に発現される遺伝子

Publications (2)

Publication Number Publication Date
JP2012143242A JP2012143242A (ja) 2012-08-02
JP2012143242A5 true JP2012143242A5 (https=) 2013-03-14

Family

ID=22640304

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001551099A Expired - Fee Related JP5250168B2 (ja) 2000-01-10 2001-01-09 乳癌において差次的に発現される遺伝子
JP2012071880A Withdrawn JP2012143242A (ja) 2000-01-10 2012-03-27 乳癌において差次的に発現される遺伝子

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2001551099A Expired - Fee Related JP5250168B2 (ja) 2000-01-10 2001-01-09 乳癌において差次的に発現される遺伝子

Country Status (9)

Country Link
US (1) US7605246B2 (https=)
EP (2) EP1985701B1 (https=)
JP (2) JP5250168B2 (https=)
AT (1) ATE402258T1 (https=)
AU (1) AU2001229367A1 (https=)
DE (1) DE60134956D1 (https=)
ES (2) ES2386317T3 (https=)
PT (1) PT1248841E (https=)
WO (1) WO2001051515A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
EP0127839B1 (en) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
CA2121038C (en) 1992-08-13 2002-05-14 Akiya Yamada Oral preparation for release in lower digestive tracts
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
CA2388922A1 (en) * 1999-11-19 2001-05-25 Human Genome Sciences, Inc. 23 human secreted proteins

Similar Documents

Publication Publication Date Title
WO2011031482A3 (en) Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
WO2010107740A8 (en) Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
AR063153A1 (es) Anticuerpo monoclonal para prevenir/tratar el cancer
MX2011009751A (es) Tratamiento de enfermedades relacionadas con factor nuclear (eritroide derivado 2) tipo 2 (nrf2) por inhibicion del transcrito antisentido natural a nrf2.
EP2475775A4 (en) MICROORGANISMS AND METHOD FOR THE SIMULTANEOUS PREPARATION OF ISOPROPANOL AND PRIMARY ALCOHOLS, DIOLES AND ACIDS
MX2011010908A (es) Anticuerpos anti-tnf-alfa y sus usos.
JP2014138843A5 (https=)
TN2013000427A1 (en) Modified acid alpha glucosidase with accelerated processing
WO2011082409A3 (en) Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
WO2012009402A3 (en) Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
WO2010135695A3 (en) TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3
IN2015DN01349A (https=)
JP2012143242A5 (https=)
NZ594347A (en) Antibodies against human tweak and uses thereof
Sharma et al. Effect of Aquazyn-TM-1000, a probiotic on the water quality and growth of Cyprinus carpio var. communis (L.)
JP2005523891A5 (https=)
ITMO20050166A1 (it) Procedimento per l'acquisizione,il trattamento e la trasmissione di dati legati al consumo energetico umano durante l'attivita'quotidiana e o la pretica sportiva e relativo dispositivo.
CN202027889U (zh) 一种注氢理疗帽
Wang et al. The inhibition of Hydrilla verticillata on Microcystis aeruginosa
CN102246875A (zh) 一种清喉保健茶
MX376386B (es) Composiciones para usarse en el tratamiento de patologías del tejido de cartílago y disco.
CN103585232A (zh) 野菊花汁
HU et al. Principle and applications of RAD-seq in studies of aquatic organisms
WO2009048326A3 (en) Preparation for treatment of a pulmonary disease
Chen et al. Study on eco-remediation in urban-ponds: restoring submerged macrophytes